近日,由重慶醫(yī)科大學(xué)病毒性肝炎研究所黃愛龍領(lǐng)銜的研究團隊,在期刊《Signal Transduction and Targeted Therapy》發(fā)表研究論文“O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N6-methyladenosine-dependent manner”,闡述了HBV感染引起肝癌發(fā)生與進展的新機制。